In breast cancer, for instance, EphB4–ephrin-B2 forward signaling exerts tumor-suppressive effects, whereas ligand-independent EphB4 activity can promote tumor growth and invasion depending on the cellular context [199,221]. Here, EPHB4 is linked to breast carcinoma.